Ionophoric polyethers are produced by the exquisitely stereoselective oxidative cyclization of a linear polyketide, probably via a triepoxide intermediate. We report here that deletion of either or both of the monBI and monBII genes from the monensin biosynthetic gene cluster gave strains that produced, in place of monensins A and B, a mixture of C-3-demethylmonensins and a number of minor components, including C-9-epimonensin A. All the minor components were efficiently converted into monensins by subsequent acid treatment. These data strongly suggest that epoxide ring opening and concomitant polyether ring formation are catalyzed by the MonB enzymes, rather than by the enzyme MonCII as previously thought. Consistent with this, homology modeling shows that the structure of MonB-type enzymes closely resembles the recently determined structure of limonene-1,2-epoxide hydrolase from Rhodococcus erythropolis.
Introduction
Cyclic polyethers represent an important and extensive family of polyketide natural products. These include a large number of polyether antibiotics [1] , as well as highly elaborate marine toxins, such as brevetoxin [2] and maitotoxin [3] . Monensins A and B are typical polyether antibiotics, acting as specific ionophores to dissipate ionic gradients across cell membranes [4] . As early as 1974, Westley proposed that the polyether tetrahydrofuran and tetrahydropyran rings were formed by the sequential opening of a polyepoxide precursor [5] . On the basis of later experiments with labeled precursors, the biosynthesis of monensins was accordingly proposed to involve the intermediacy of a linear E-, E-, E-polyketide triene [6] , which is stereospecifically epoxidized to a triepoxide. The triepoxide then undergoes a cascade of S N 2 epoxide openings to give a unique polyether product (Figure 1 ). An alternative mechanistic proposal, based on chemical precedent, invoked iron oxetane intermediates, starting from a Z-, Z-, Z-triene [7] . More recently, information from the sequencing of the monensin [8, 9] and nanchangmycin [10] biosynthetic gene clusters has given support to the main outlines of the triepoxide hypothesis. Each cluster contains genes encoding a non-haem, flavin-dependent monooxygenase (monCI and nanO) and an enzyme displaying homology to authentic epoxide hydrolases (monCII and nanE) that could function as the key epoxide-opening cyclase enzyme [8] [9] [10] . Two novel genes (monBI and monBII), whose products show significant sequence similarity to known D 5 -3-ketosteroid isomerases [11] , were also found in the monensin cluster. This prompted the suggestion [8, 9] that the products of these genes might isomerize two trisubstituted double bonds on the growing polyketide chain in order to produce a Z-, Z-, E-triene intermediate that could also undergo stereospecific epoxidation and ring opening to monensin. The counterpart in nanchangmycin biosynthesis is the internally duplicated nanI gene that appears to comprise monBI and monBII homologs fused head to tail [10] . This suggested role for MonB and NanI proteins has however been undermined by our recent finding that a mutant of the monensin-producing strain of Streptomyces cinnamonensis, in which monCI has been deleted, accumulates a triene shunt metabolite that has the E-, E-, E-configuration exclusively [12] . Meanwhile, other recent work in our laboratory has shown that the enzyme originally thought to function as the key epoxide hydrolase/cyclase (MonCII) is likely to be involved in polyketide chain release [13] . This has prompted us to reexamine the role of the MonB proteins, and especially their possible function as epoxide hydrolases/cyclases.
Results and Discussion
MonBI as a Putative Epoxide Hydrolase and Member of the Adaptable a + b Barrel Fold Superfamily Comparison of the MonB and NanI proteins to proteins in the PDB database by using the program FUGUE [14] readily identified their striking similarity to an emerging family of proteins sharing the same fold but having diverse catalytic or binding activities. The archetype of this family is scytalone dehydratase, which catalyzes key steps in the fungal synthesis of melanin, involving a-proton abstraction, leading to elimination of water and aromatization [15] . Other prominent members include the following enzymes whose crystal structures have also been determined to high resolution: limonene-1,2-epoxide hydrolase from Rhodococcus erythropolis (PDB entry 1NWW, 1.2 Å ) [16] ; the polyketide cyclase SnoaL from Streptomyces nogalater (PDB entry 1SJW, 1.3 Å ), which catalyzes intramolecular aldol condensation in the closure of the A ring of the anthracycline antibiotic nogalamycin [17] ; and D 5 -3-ketosteroid isomerase from Pseudomonas putida (PDB entry 1OPY, 1.9 Å ) [18] . Analysis of the superimposed 3D structures of 1NWW, 1SJW, and 1OPY with DALI (http://www.ebi. ac.uk/dali/) [19] reveals a highly conserved fold, with the maximum rms deviation ranging between 2.4 Å (between 1OPY and 1SJW) and 2.0 Å (between 1NWW and 1OPY). The closest structural template for MonBI and MonBII is the limonene epoxide hydrolase from R. erythropolis [16] , and the alignment of its sequence with those of the MonB and NanI proteins clearly shows the high conservation of secondary structural elements ( Figure 2A ). The 3D model generated for MonBI corresponds to a single domain that has been dubbed the adaptable a + b barrel fold [20] . The close superimposition of the modeled structure on the template is shown in Figure 2B . The a + b barrel fold comprises a curved, sixstranded mixed b sheet, with four a helices packed onto it to create a barrel-like structure housing a conical pocket open at its larger end. Most residues lining this pocket are hydrophobic, as in the other proteins of this family. In all other proteins of the family, the pocket contains the active site, and a number of polar amino acid residues are present here and play a role in catalysis. For example, as shown in Figure 2C , the active site of limonene epoxide hydrolase contains two aspartate residues, one (D101) acting as a general acid to promote opening of the epoxide ring, and the other (D132) acting as a general base to assist the nucleophilic attack of a water molecule. A tyrosine residue (Y53) is also proposed to participate as a general base. Likewise, for the ketosteroid isomerases [11, 18] , a conserved aspartic acid (corresponding to D37 in MonBI; Figure 2A ) is the key general base that abstracts the proton from the substrate. The MonB and NanI proteins do not share conserved active site residues with any of the previously studied proteins of this superfamily. However, between MonBI, MonBII, and the domains NanIa and NanIb, there are a number of wholly conserved polar residues, including ones (for example, E36 and E64) that are predicted to lie deep within the hydrophobic pocket (Figure 3B) and that are plausible candidates as active site residues involved in acid-base catalysis. Although such ideas require experimental testing, this detailed analysis serves to confirm that the inferred structure of the MonB and NanI proteins is compatible with the proposal made here: that they function as epoxide hydrolases akin to limonene epoxide hydrolase.
Small-Angle X-Ray Scattering Confirms a Dimeric Structure for MonBI
The quaternary structure of the members of the adaptable a + b barrel fold family is highly variable, ranging from dimeric (limonene epoxide hydrolase [16] , D 5 -3ketosteroid isomerase [18] ) to trimeric (scytalone dehydratase [15] ), tetrameric (SnoaL [17] ), and even tetradecameric (a subunit of calmodulin-dependent kinase II [21] ). The MonBI protein was initially modeled as a homodimer based on its similarity with limonene epoxide hydrolase (1NWW). The two monomers of the symmetrical dimer pack against each other via hydrophobic and electrostatic interactions that involve the side chains of residues on the ''back face'' of the b sheet. A similar dimeric interface has been observed in the crystal structures of 3-oxo-D 5 -steroid isomerase (1OPY) and limonene epoxide hydrolase (1NWW). It is also found in the polyketide cyclase SnoaL (1SJW), which is organized as a dimer of dimers.
Expression and purification of histidine-tagged MonBI protein from recombinant Escherichia coli (see Experimental Procedures) allowed direct estimation of its molecular mass and analysis of its quaternary structure. As judged by gel filtration (data not shown), the protein appeared dimeric. Small-angle X-ray scattering (SAXS) was then carried out on MonBI in solution to confirm its oligomeric structure and to probe its overall size and shape [22] . Shape reconstruction from these data showed an excellent fit of the experimentally determined electron density envelope of the protein to that predicted on the basis of the homology model ( Figure 3A and Supplemental Data available with this article online).
Deletion of the monB Genes
In-frame deletion mutants deficient in one or both of the monB genes of S. cinnamonensis were produced as described previously [9] . Each of the mutants (ABDBI and ABDBII and the double mutant ABDBIBII) was fermented in monensin production medium, and extracts were analyzed by LC-MS and compared to those from wild-type S. cinnamonensis. The LC-MS profiles of the mutants appeared to be identical in each case and very different from wild-type (Supplemental Data). No trace of either monensin A (retention time of 17 min) or monensin B (retention time of 15 min) was found, confirming that the monB genes are essential for monensin production [9] , but also extending that analysis to show the presence, as major products of all three mutants, of the C3-demethyl analogs of monensin A and B, at about 5% of the levels of monensins normally seen in wild-type extracts. Numerous minor components were also present, eluting with retention times between 3 and 10 min under these conditions (see Supplemental Data). Isolation and Characterization of epi-Monensin A In order to facilitate the isolation of minor metabolites, the monBII gene was deleted in a monensin-overproducing industrial strain of S. cinnamonensis exactly as for wild-type. From the fermentation extracts of this strain, a metabolite was obtained with the same accurate molecular mass as monensin A, but with a retention time of 16 min (i.e., about 1 min earlier than monensin A). NMR analysis, including 1 H-NMR NOESY data (Supplemental Data), suggested that this monensin isomer is the C-9-epimer, epi-monensin A. This metabolite, which is not present in wild-type S. cinnamonensis cultures, differs from monensin A only in the stereochemistry of the spiroketal center. The fragmentation of the metabolite in electrospray MSMS also differed characteristically from that of monensin A [23] .
Spiroketals epimerize under acidic conditions to the more thermodynamically favored configuration [24] . We thus predicted that our putative C-9-epimer should revert to authentic monensin A and confirm our interpretation of the NMR data. Treatment of epi-monensin A with HF [25] did indeed result in complete conversion [8, 9] , Nan1A and Nan1B (the N-and C-terminal halves of NanI, respectively) from Streptomyces nanchangensis [10] , and limonene-1,2-epoxide hydrolase from Rhodococcus erythropolis (LEH) (PDB entry 1NWW) [16] . Secondary structural elements of LEH are shown in EScript format (http://escript.ibcp.fr/EScript/cgi-bin/EScript. cgi). (B) Superposition of the modeled structure of MonBI and the crystal structure of LEH (INWW). For clarity, only one protomer each of MonB1 and of LEH is shown, although both proteins are dimers in solution (see the text). (C) Proposed reaction mechanism of the LEHcatalyzed reaction (redrawn from [16] ). to monensin A. Subsequently, a much more abundant novel metabolite, the C-26-deoxy analog of epi-monensin A, was also isolated from the fermentation extracts of the mutant and eluted with a retention time of 20 min (data not shown). This compound was also readily converted into C-26-deoxymonensin A by treatment with HF. It appears that C-26-deoxy-epi-monensin A is a poor substrate for MonE, the cytochrome P450 hydroxylase that is responsible for hydroxylation of the terminal C-26 position [8, 9] .
Nonenzymatic Cyclization to Form Monensins
If MonBI and MonBII have been correctly identified as the enzymes that control the conversion of a triepoxide intermediate, probably protein-bound, into a polyether, then in their absence such intermediates should accumulate. The products seen in fermentation extracts of monB mutants ought then to reflect a balance between the chemical degradation of such species, their chemical or enzymatic release if they are protein bound, and the specificity of the C-3-O-methyltransferase and C-26-hydroxylase enzymes that are present as part of the monensin biosynthetic pathway. The observation that C-3-O-demethylmonensins A and B are the major products from all monB mutant strains shows, first, that epoxide ring opening and formation of the polyether rings with the correct regio-and stereospecificity is a chemically favored process under these conditions. Second, it shows that O-methylation at C-3 occurs either before polyether ring formation or before release of the monensin product from a protein, or both. Further, it seems that in the absence of methylation at C-3-OH, nucleophilic attack by the C-5 hydroxyl group on the C-9 carbonyl takes place preferentially to form the natural epimer of the spiroketal. This nonenzymatic kinetic control means that the subsequent cyclization gives C-3-O-demethylmonensins with the correct configuration ( Figure 4 ).
Once the A ring has formed (Figure 4 ), the resulting hemiacetal hydroxyl opens the first epoxide to form the B ring, by nucleophilic attack at the more hindered carbon and with inversion at this center. This chemical preference can be rationalized on the basis that the alternative attack at the less hindered carbon would be a kinetically disfavored 6-endo-tet cyclization in violation of Baldwin's rules [26] . Also, inversion at the tertiary center can be understood if acid catalysis promotes significant opening of the epoxide in the transition state, allowing the developing carbocation to be captured by the incoming hydroxyl nucleophile. This ''loose S N 2'' mechanism avoids the sterically disfavored S N 2 mechanism, while ensuring stereochemical inversion. Such a mechanism has been exploited in the construction of synthetic cyclic polyethers [27, 28] . It is also the basis of the mechanism proposed for limonene epoxide hydrolase [16] ( Figure 3C ). The same principles would apply to subsequent closure of the C ring of monensin (Figure 4 ). Formation of the D ring also involves a favorable exo-tet S N 2 ring closure, and the final reversible hemiacetal ring closure would be expected to give the natural configuration as the thermodynamically favored product.
The isolation of epi-monensins A and B and of C-26deoxy-epi-monensins A and B as minor products from strains mutant in either or both of the monB genes reveals a second alternative (minor) fate for putative triepoxide intermediates, in the absence of MonB proteins. If the C3-hydroxy is methylated in the tri-epoxide intermediate, the unnatural spiroketal epimer appears to be kinetically favored, leading to the epi-isomer.
Cyclization Intermediates from MonB-Deficient Strains Are Chemically Competent for Conversion into Monensins
The nature of the faster-eluting, more polar metabolites noted earlier as minor components in the LC-MS analysis of the monB mutants is crucial for our proposal that the MonB enzymes govern polyether ring formation from the putative triepoxide. These species have molecular ions coincident with those of monensin A (693.5), monensin B and demethylmonensin A (679.5), and demethylmonensin B (665.5), but they are present in quantities too small to allow direct structural determination as yet. We reasoned that if these minor components represented species at the correct oxidation state but incompletely cyclized ( Figure 5 ), then their cyclization should be accelerated by acid catalysis. The minor components were purified by HPLC, pooled, and treated with HF. Complete conversion of the material with molecular ion 679.5 to authentic C-3-O-demethyl monensin A and monensin B was observed ( Figure 6) . Similarly, the components with molecular ion 693.5 shifted to coelute with authentic monensin A, and those with molecular ion 665.5 shifted to coelute with authentic C-3-O-demethyl monensin B (data not shown). These results give strong support to the identification of the MonB enzymes as epoxide hydrolases involved in polyether ring formation. It shows, first, that C-26-hydroxylation can occur before either methylation or polyether ring formation. Second, it shows that monB genes are clearly not required for the formation of intermediate species that appear to have the correct geometry and to be at the correct oxidation level to give rise to monensins by ring opening/ cyclization. The presence of MonB enzymes apparently accelerates, but does not change, the stereochemical course of polyether ring formation, compared to the acid-catalyzed process. Control of the spiroketal center by the MonB proteins could be achieved if the relevant MonB epoxide hydrolase is highly specific [29] and accepts only one epimer of the A ring hemiacetal.
MonB-Type Enzymes as Epoxide Hydrolases Involved in Polyether Ring Formation
The product of the gene monCII, previously proposed as governing epoxide ring opening in monensin biosynthesis, shows significant sequence and structural similarity, over about 260 amino acids, to the epoxide hydrolases of the a,b hydrolase family [30] . However, closer examination has revealed that the active site nucleophile in MonCII would be a serine residue rather than the conserved aspartate residue of this family; thus, the normal acyl intermediate would be replaced in MonCII by a much more stable ether intermediate. Also, few of these epoxidases are known to hydrolyze trisubstituted epoxides, in contrast to the limonene epoxide hydrolase [18] . As will be discussed elsewhere [13] , we have reassigned MonCII as a thioesterase required for release of protein bound intermediates in monensin biosynthesis.
Since neither MonBI nor MonBII can support monensin biosynthesis on its own, the respective roles of MonBI and MonBII in catalyzing the successive formation of the polyether rings in monensin remain to be determined. The pattern of products in MonBI-and MonBIIdeficient mutants appears to be identical, which argues that their actions are somehow coordinated. The protein NanI, involved in nanchangmycin biosynthesis, carries homologs of MonBI and MonBII in, respectively, its Nterminal and C-terminal halves [10] (Figure 2A ). Further homology modeling (data not shown) suggests that MonBI and MonBII could, in principle, exist as a heterodimer in S. cinnamonensis. Whatever the protein arrangement turns out to be, from the present results it is clear that each ring closure in polyether formation occurs stepwise in a definite order, under enzymatic control of one or more MonB-type enzymes.
This model can be extended to the biosynthesis of much more complex polyethers, such as brevetoxin. As has been previously pointed out [31] , if the stepwise or cascade opening of a polyepoxide is invoked [32] to explain the biosynthesis of this marine toxin, it must involve a series of nine successive endo-tet cyclizations, each kinetically disfavored and in violation of Baldwin's rules. It is thus highly unlikely that a spontaneous, nonenzymatic cascade of epoxide openings is occurring here. A stepwise mechanism, as proposed for monensin cyclization, is much more attractive (see Figure 7 ). Successive closure of each ring by a highly specific epoxide hydrolase would present the substrate for the next epoxide hydrolase. In this case, each substrate is stereochemically identical, so only one MonB-like enzyme might be required to carry out all nine cyclizations.
Significance
Monensin is one of the most studied polyether antibiotics and is from one of the largest classes of bioactive polyketide natural products. Biosynthesis of polyethers involves polyketide chain formation on a modular polyketide synthase and a remarkable process of oxidative cyclization. Monensin biosynthesis has been proposed to involve a triepoxide intermediate that undergoes regiospecific and stereospecific ring opening and concomitant polyether ring formation, but the enzymology has remained obscure. We show here, from analysis of the polyketide products of mutations in the monB genes of the monensin biosynthetic gene cluster, together with homology modeling of the MonB enzymes by using the recently determined structure of limonene epoxide hydrolase as a structural template, that the MonB enzymes, previously tentatively assigned as isomerases involved in altering the configuration of the initially formed polyketide, are the key epoxide hydrolase/cyclase enzymes in monensin biosynthesis. Based on this analysis, MonB-like enzymes may also be involved in the formation of the spectacular ladder polyether structures of marine toxins such as brevetoxin. These insights open the way to a complete deconvolution of the enzymology of polyether biosynthesis and will facilitate the engineering of polyether biosynthetic pathways to produce altered bioactive products.
Experimental Procedures

Culture Conditions
Seed cultures of wild-type and monensin-overproducing strains of Streptomyces cinnamonensis and monB-deficient mutants of these strains were grown in tryptic soy broth medium in flasks fitted with springs at 30ºC and 200 rpm for 24 hr. These cultures (2.5 ml) were then used to inoculate 25 ml of either a proprietary germinative medium (I. Agayn, personal communication) or SM16-1 medium [9] in a 250 ml Erlenmeyer flask and were grown at 32ºC and 200 rpm for 24-48 hr. From these seed cultures, each 2.5 ml portion was used to inoculate 40 ml of either an oil-based monensin production medium or SM16-1 in a 250 ml Erlenmeyer flask. The cultures were grown at 32ºC and 200 rpm for 12 days. The relative humidity was maintained at 90%. Flasks were weighed before the start of fermentation, and any loss by evaporation was compensated for with sterile water.
Extraction and Purification of epi-Monensin A The combined culture broth (1 liter) was centrifuged at 7500 rpm for 45 min, the supernatant was extracted three times with ethyl acetate (800 ml), and the combined organic fractions were evaporated in vacuo. The residue was redissolved in hexane and shaken vigorously with an equal volume of methanol:water (75:25 v/v). This mixture was then centrifuged at 7500 3 g for 30 min, and the methanolic layer was removed. This was repeated twice with fresh methanol: water. The combined methanolic fractions were evaporated in vacuo and then lyophilized. The oily extract was dissolved in minimal ethyl acetate and passed twice through a silica column (35 3 100 mm), eluting with ethyl acetate:methanol (95:5). The solvent was removed in vacuo, and the residue was redissolved in minimal ethyl acetate and loaded onto a silica column (35 3 110 mm) packed in ethyl acetate (containing 5% methanol v/v):dichloromethane (2:1 v/v) and eluted with the same solvent mixture. Fractions were analyzed by LC-MS, and those containing the desired product were combined and evaporated in vacuo. This sample was then further purified through silica by using the same method as in the previous step. The relevant fractions (from LC-MS analysis) were pooled, and the solvent was removed. The sample was then redissolved in methanol (1.5 ml) and purified by preparative HPLC by using a Phenomenex Luna 10 mm C18(2) reverse-phase column (2120 3 250 mm). The solvent gradient used was from 80% methanol, 20% aqueous ammonium acetate (20 mM) to 100% methanol over 30 min, at a flow rate of 15 ml min 21 . Fractions were collected at 30 s intervals and analyzed by LC-MS. The fractions containing pure epi-monensin A were combined and evaporated as much as possible in vacuo and lyophilized. The product was then desalted by using an Isolute C18(EC) 500 mg cartridge (Jones Chromatography Ltd., Pontypridd, UK), and the product was lyophilized to yield C-9-epi-monensin A (w250 mg) as a white powder. Other metabolites were purified in the same manner.
Epimerization of epi-Monensin A
A sample of epi-monensin A (w5-10 mg) was dissolved in acetonitrile (1 ml). One drop of 48% aqueous hydrofluoric acid was added, and the reaction mixture was stirred at room temperature for 2 hr. The reaction mixture was adjusted to wpH 9 with aqueous sodium hydroxide (1 M) , and the acetonitrile was removed in vacuo. The aqueous residue was extracted twice with ethyl acetate (1.5 ml), the organic extracts were combined and dried over anhydrous MgSO 4 , and the solvent was removed. The sample was dissolved in HPLC-grade methanol (200 ml) and analyzed by LC-MS.
Cyclization of Intermediates Obtained from Cultures of S. cinnamonensis monB Mutants Shake cultures were grown in SM16-1 medium [9] from a tryptic soy broth inoculum for 5 days at 30º and 200 rpm. The culture broth supernatant (50 ml) was extracted twice with ethyl acetate (50 ml), and the combined fractions were dried and then evaporated in vacuo. The crude product was adsorbed to a plug of silica and eluted with ethyl acetate, and the dried product was redissolved in methanol. The extract was analyzed by LC-MS, and the early-eluting metabolites were collected separately. These were dried, redissolved in acetonitrile, and treated with hydrofluoric acid, as described for the epimerization of epi-monensin A.
Mass Spectrometric Analysis of epi-Monensin A Accurate mass analyses were performed on a BioApex II (4.7 Tesla) Fourier-transform cyclotron resonance instrument (Bruker Daltonics, Billerica, MA). Solutions were infused from the Analytica ESI source at 100 ml min 21 . CID fragmentation was performed on the isolated ions with CO 2 as the collision gas.
Expression and Purification of MonBI from Recombinant Escherichia coli
The monBI gene was amplified by PCR by using cosmid S23 encoding part of the monensin gene cluster as template [20] and oligonucleotide primers 5 0 -monB3-NdeI (5 0 -CGCATATGAACGAGTTCGCCC GCAAG-3 0 ) and 3 0 -MonB3-NotI (5 0 -TAGCGGCCGCGCCGAGGACC GTGAGAT-3 0 ), which introduced, respectively, an NdeI site at the 5 0 end and a NotI site at the 3 0 end. The purified fragment was cloned in pUC18, excised as a NdeI-NotI fragment, and ligated into expression plasmid pET-20b(+) (Novagen), which had been cut with the same enzymes. This gave plasmid pMonB3-20, encoding MonBI with a C-terminal hexahistidine tag, housed in E. coli strain BL21-CodonPlus (DE3)-RP (Stratagene). A single colony of this recombinant strain was used to inoculate 10 ml LB medium supplemented with glucose (1 g/liter), 50 mg/liter carbenicillin, and 34 mg/liter chloramphenicol, and the culture was grown overnight at 30ºC, then used as an inoculum for 1 liter LB medium supplemented as described above. When the absorbance at 600 nm reached 0.8, IPTG was added to 0.5 mM concentration, and induction was allowed to proceed for 3 hr. Cells were harvested by centrifugation at 5000 3 g for 20 min at 4ºC to yield approximately 3 g wet weight of cells. The cells were suspended in 600 mM potassium phosphate buffer (pH 7.5), containing 400 mM NaCl, 5 mM imidazole, and 1 mM phenylmethanesulphonyl fluoride, and disrupted by two successive passages through a French pressure cell operated at 1000 psi. Cell debris was removed by centrifugation, the cleared lysate was incubated with 1 ml Ni-NTA resin (Qiagen), and the mixture was gently agitated on a rotary shaker at 4ºC for 1 hr. The resin was packed into a column, and, after washing with the same buffer, MonBI was eluted by a linear gradient of increasing imidazole concentration (up to 250 mM imidazole) in the same buffer, in 40 fractions each of 5 ml, at 1 ml/min. The fractions containing essentially pure MonBI were desalted on a small HiPrep column (Pharmacia Biotech), concentrated by using a spin concentrator (molecular weight Cut off of 5000 Da) (Millipore), and stored frozen at 280ºC.
Small-Angle X-Ray Scattering Analysis of MonBI Protein
Data were collected at Station 2.1, Synchrotron Radiation Source, Daresbury Laboratory by using a 2D multiwire proportional counter at sample-to-detector distances of 1.25 and 4.25 m. Data from matching buffers (50 mM Tris-HCl buffer [pH 7.0] and 100 mM NaCl) were collected and subtracted from the protein profiles. MonB1 solutions at concentrations ranging from 4 to 10 mg/ml and pH 4-8 were analyzed at 20ºC. The radius of gyration, R g ; the maximum particle dimension, D max ; and the intraparticle distance distribution function, (p[r]), were calculated from the scattering data by using the indirect Fourier transform method program Gnom [33] . Molecular shapes were reconstructed from the scatter-ing profile (after merging high-and low-resolution data) by using the ab initio procedure of simulating annealing with clustered spheres representing amino acid residues (Gasbor versions 1.8 and 2.0) [34] . Shape reconstruction results in a 3D arrangement of scattering centers (spheres 3.5 Å in diameter) that reproduce the 1D scattering curve in accordance with the experimental data. These are displayed by using the space fill option to produce the overall molecular shape.
Similarity Search and Protein Modeling
The sequence of MonBI was compared with all protein sequences deposited in SWISS-PROT by using the Blast v2.0 program [35] . A PSI-BLAST search produced an alignment between MonBI and homologous proteins that highlights conserved residues in the epoxide hydrolase family. Homologous proteins with known structure were identified by using the FUGUE [14] homology recognition server. FUGUE searches for homologs in the structural profile library derived from the structure-based alignments in the HOMSTRAD database [36] and, using the environment-specific substitution tables, automatically generates the best alignments for the top hits. The alignment produced by FUGUE for the highest-scoring hit was formatted with JOY [37] and was analyzed visually to highlight the conservation of structurally and functionally important residues. The model of MonBI was constructed with MODELLER [38] . A final energy and structure minimization was done by using the SYBYL (Tripos, Inc., St. Louis, MO) force field. The model was validated with PROCHECK [39] , VERIFY3D [40] , JOY, and by visual inspection with 3D graphics software. Computer renderings of structures were created by using the program PyMOL [41] .
Supplemental Data
Supplemental Data including LC-MS, NMR data for epi-monensin, details of protein expression and purification, and SAXs data for MonBI are available at http://www.chembiol.com/cgi/content/full/ 13/4/453/DC1/.
